A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes.

Source:http://linkedlifedata.com/resource/pubmed/id/20843837

Clin. Cancer Res. 2010 Oct 15 16 20 4978-89

Download in:

View as

Triples

General Info

PMID
20843837